471 related articles for article (PubMed ID: 31403666)
1. Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review.
Colombel JF; D'haens G; Lee WJ; Petersson J; Panaccione R
J Crohns Colitis; 2020 Feb; 14(2):254-266. PubMed ID: 31403666
[TBL] [Abstract][Full Text] [Related]
2. Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further?
Dal Buono A; Roda G; Argollo M; Zacharopoulou E; Peyrin-Biroulet L; Danese S
Expert Rev Gastroenterol Hepatol; 2020 Sep; 14(9):807-817. PubMed ID: 32762582
[TBL] [Abstract][Full Text] [Related]
3. Treat to target in Crohn's disease: A practical guide for clinicians.
Srinivasan AR
World J Gastroenterol; 2024 Jan; 30(1):50-69. PubMed ID: 38293329
[TBL] [Abstract][Full Text] [Related]
4. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Turner D; Ricciuto A; Lewis A; D'Amico F; Dhaliwal J; Griffiths AM; Bettenworth D; Sandborn WJ; Sands BE; Reinisch W; Schölmerich J; Bemelman W; Danese S; Mary JY; Rubin D; Colombel JF; Peyrin-Biroulet L; Dotan I; Abreu MT; Dignass A;
Gastroenterology; 2021 Apr; 160(5):1570-1583. PubMed ID: 33359090
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
Bryant RV; Winer S; Travis SP; Riddell RH
J Crohns Colitis; 2014 Dec; 8(12):1582-97. PubMed ID: 25267173
[TBL] [Abstract][Full Text] [Related]
6. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Peyrin-Biroulet L; Sandborn W; Sands BE; Reinisch W; Bemelman W; Bryant RV; D'Haens G; Dotan I; Dubinsky M; Feagan B; Fiorino G; Gearry R; Krishnareddy S; Lakatos PL; Loftus EV; Marteau P; Munkholm P; Murdoch TB; Ordás I; Panaccione R; Riddell RH; Ruel J; Rubin DT; Samaan M; Siegel CA; Silverberg MS; Stoker J; Schreiber S; Travis S; Van Assche G; Danese S; Panes J; Bouguen G; O'Donnell S; Pariente B; Winer S; Hanauer S; Colombel JF
Am J Gastroenterol; 2015 Sep; 110(9):1324-38. PubMed ID: 26303131
[TBL] [Abstract][Full Text] [Related]
7. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by "tight control"?
Gonczi L; Bessissow T; Lakatos PL
World J Gastroenterol; 2019 Nov; 25(41):6172-6189. PubMed ID: 31749591
[TBL] [Abstract][Full Text] [Related]
8. Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?
D'Arcangelo G; Aloi M
Paediatr Drugs; 2020 Oct; 22(5):463-472. PubMed ID: 32572841
[TBL] [Abstract][Full Text] [Related]
9. Review article: Translating STRIDE-II into clinical reality - Opportunities and challenges.
Dignass A; Rath S; Kleindienst T; Stallmach A
Aliment Pharmacol Ther; 2023 Sep; 58(5):492-502. PubMed ID: 37382397
[TBL] [Abstract][Full Text] [Related]
10. 'Treat to Target' - Lessons Learnt.
Kurti Z; Vegh Z; Golovics PA; Lakatos PL
Dig Dis; 2016; 34(1-2):147-52. PubMed ID: 26981855
[TBL] [Abstract][Full Text] [Related]
11. Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.
Sandborn WJ; Hanauer S; Van Assche G; Panés J; Wilson S; Petersson J; Panaccione R
J Crohns Colitis; 2014 Sep; 8(9):927-35. PubMed ID: 24713173
[TBL] [Abstract][Full Text] [Related]
12. Treat-to-target approach in the management of inflammatory Bowel disease.
Nuñez F P; Mahadevan U; Quera R; Bay C; Ibañez P
Gastroenterol Hepatol; 2021 Apr; 44(4):312-319. PubMed ID: 33070988
[TBL] [Abstract][Full Text] [Related]
13. Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
Agrawal M; Colombel JF
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):421-436. PubMed ID: 31078245
[TBL] [Abstract][Full Text] [Related]
14. Treat to target in inflammatory bowel disease: a survey of treatment strategies amongst Portuguese doctors.
Bernardo S; Fernandes SR; Araújo-Correia L
Rev Esp Enferm Dig; 2019 Aug; 111(8):593-597. PubMed ID: 31190548
[TBL] [Abstract][Full Text] [Related]
15. [Evolving Therapeutic Strategies in the Inflammatory Bowel Disease].
Na SY; Moon W
Korean J Gastroenterol; 2018 Feb; 71(2):61-68. PubMed ID: 29471602
[TBL] [Abstract][Full Text] [Related]
16. Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease.
West J; Tan K; Devi J; Macrae F; Christensen B; Segal JP
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834936
[TBL] [Abstract][Full Text] [Related]
17. Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.
Christensen B; Rubin DT
Curr Gastroenterol Rep; 2016 Jan; 18(1):5. PubMed ID: 26759147
[TBL] [Abstract][Full Text] [Related]
18. Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases.
Colombel JF; Narula N; Peyrin-Biroulet L
Gastroenterology; 2017 Feb; 152(2):351-361.e5. PubMed ID: 27720840
[TBL] [Abstract][Full Text] [Related]
19. Multi-item Measures for Paediatric Inflammatory Bowel Diseases: The ABCs of All Those Acronyms.
Ledder O; Turner D
J Crohns Colitis; 2023 Jul; 17(7):1154-1168. PubMed ID: 36734262
[TBL] [Abstract][Full Text] [Related]
20. How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission?
Dulai PS; Jairath V
Clin Gastroenterol Hepatol; 2020 May; 18(6):1300-1308. PubMed ID: 31887449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
